Full-Time

Lab Assistant

Stability Coordinator, Pharmaceutical Manufacturing

Granules

Granules

501-1,000 employees

Vertically integrated API and dosage manufacturer

Compensation Overview

$19 - $22/hr

Chantilly, VA, USA

In Person

Bachelor's, Associate's

Category
Biology & Biotech (1)
Required Skills
Data Analysis

Get referred to Granules

See people who can refer or advise you

Requirements
  • A minimum Associate’s Degree is required; a Bachelor’s degree in pharmacy, chemistry, or a related scientific field is preferred.
  • 0–2 years of experience in a quality control laboratory is required.
  • Knowledge of and ability to work with equipment, supplies, components, and technical areas used in the pharmaceutical industry are required.
  • Knowledge of Food and Drug Administration guidelines on stability requirements is preferred.
  • The ability to analyze data accurately is required.
  • The ability to organize work and complete duties in a timely manner is required.
  • Flexibility and the ability to handle multiple activities are required.
  • Excellent computer skills and verbal and written communication skills are required.
  • The ability to work in a team environment is required.
  • The role requires prolonged sitting, standing, walking, bending, stooping, reaching, and lifting; work around powders and other chemicals; and use of protective eyewear in the laboratory or manufacturing area.
Responsibilities
  • Comply with the requirements of stability standard operating procedures.
  • Enter data and use stability software.
  • Review the stability program annually and recommend revisions when necessary.
  • Provide stability summaries to the Quality Control Director upon completion of studies.
  • Dispose of stability samples according to Good Manufacturing Practice guidelines.
  • Assist in preparing and maintaining batch records and certificates of analysis.
  • Maintain, control, and file records of raw-material and finished-product specifications.
  • Ensure that stability chambers and monitoring systems perform within required parameters.
Desired Qualifications
  • Experience in Good Manufacturing Practice quality control and/or a pharmaceutical manufacturing facility.
  • Experience in pharmaceutical stability operations.

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
  • July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
  • Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.

What critics are saying

  • FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
  • Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
  • Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.

What makes Granules unique

  • Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
  • February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
  • Granules shipped in 80 countries and won 94 approvals by August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours